The approval of the Russian Sputnik V vaccine by the World Health Organization (WHO) has been suspended until a new inspection of one of the manufacturing plants, the deputy head of the Pan American Health Organization (PAHO), Dr. Jarbas Barbosa, told reporters on Wednesday, September 15.
“Vaccine manufacturers must confirm that the locations where vaccines are produced agree with good manufacturing practice standards,” Barbosa said.
According to him, during an inspection of one of the factories, which forms part of the production of Sputnik V, it was not found that this factory agrees with the application of good manufacturing practices. Barbosa indicated that the necessary changes should be made and a new inspection requested.
On September 10, Oleg Benesh, senior specialist of the immunization department of the WHO European Office, said that the organization expects Russia to submit a full package of documents on Sputnik V, after which the drug will be assessed.
On August 17, Russian Foreign Minister Sergei Lavrov pointed to the politicization of delaying the registration process for Russian vaccines against coronavirus in the West. Lavrov noted that the European Commission is not going to do anything until Sputnik V passes the registration process with WHO.
Russian President Vladimir Putin in March pointed to growing interest in Sputnik V abroad, despite the deliberate discrediting of the vaccine and information stuffing. According to him, the statements of EU officials about the “uselessness” of the drug make one think that they are defending the interests of individual companies, not citizens.
Sputnik V was developed by specialists from the Gamaleya Center. The drug was registered in August 2020 and became the first vaccine against COVID-19 in the Russian Federation and the world.
A large-scale vaccination has been taking place in Russia since January. Citizens are vaccinated free of charge and voluntarily. Five vaccines against coronavirus have been registered in the country: Sputnik V, as well as Sputnik Light, EpiVacCorona, EpiVacCorona-N and KoviVac.
All relevant information on the situation with the coronavirus is available on the websites of stopcoronavirus.rf and access vsem.rf, as well as by the hashtag #WeVotte. Coronavirus hotline: 8 (800) 2000-112.